Focus:
Comment
-
2 April 2020
Significant unmet needs remain in the global psoriatic arthritis market
Despite the plethora of drugs currently available for patients with psoriatic arthritis, several key unmet needs remain. GlobalData has identified four key unmet needs in this disease space, which are...
-
1 April 2020
Similarities Between Covid-19 Symptoms and Psychiatric Disorders Can Exacerbate Existing Mental Health Issues
Outbreaks of Covid-19 have affected more than 150 countries and have killed more than 42,000 people worldwide. With an ever-increasing death toll and an infection rate that is higher than...
-
1 April 2020
US Covid-19 cases projected to increase 65% by 5 April
In the key markets most heavily affected by Covid-19, GlobalData epidemiologists expect the case trend in the next weeks to follow their low-risk forecast, with the exception of US Covid-19...
-
1 April 2020
Antimalarial drugs could provide a treatment solution for Covid-19
On 23 March, the US Food and Drug Administration (FDA) lifted an import ban it had imposed in 2015 on India’s Ipca Laboratories due to quality issues and non-adherence to...
-
31 March 2020
Nearly 70 potential Covid-19 drug and experimental compound candidates identified
Researchers from the Quantitative Biosciences Institute (QBI) Covid-19 Research Group (QCRG) at the University of California, San Francisco (UCSF) and their collaborators have identified 69 potential Covid-19 drug candidates and...
-
31 March 2020
Covid-19: emerging findings and implications in cardiovascular and metabolic disorders
The Covid-19 pandemic raging across the globe has a multitude of implications across healthcare sectors and disease indications. The cardiovascular and metabolic disorder (CVMD) space is no exception, as Covid-19...
-
30 March 2020
People at risk of severe Covid-19 make up 15% of the 9MM population
Coronavirus disease 2019 (Covid-19), declared a pandemic by the World Health Organization (WHO) on 11 March 2020, has now spread across 175 countries with approximately 480,000 total confirmed cases worldwide,...
-
30 March 2020
Influenza drug Favipiravir being tested to treat COVID-19
Treatment options for COVID-19 are urgently needed as the total number of confirmed cases globally rises to 550,000 on Friday and the US becomes the country with the most confirmed...
-
30 March 2020
Triplet combinations emerging in the first-line treatment of melanoma
Immune checkpoint inhibitors (ICIs) have led a shift away from mainstay cytotoxic agents and targeted therapies in the treatment of cancer, largely due to the unprecedented improvement in survival outcomes...
-
27 March 2020
More data needed to support the use of hydroxychloroquine for Covid-19
Recently, President Trump has noted the use of hydroxychloroquine and chloroquine as treatment options for patients with Covid-19 and subsequently ordered the FDA to grant approval on the grounds of...